Toxic effects of subchronic T-2 toxin exposure on systemic immune deficiency in developing juvenile rats

Fanshuang Meng1, Junfeng Zhou1, Hongyu Wang1

  • 1Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin 150081, China; NHC Key Laboratory of Etiology and Epidemiology (Harbin Medical University), China.

Insights

T-2 toxin exposure in juvenile rats caused significant immune system damage, including organ atrophy and reduced immune cell function. This highlights the developing immune system's vulnerability to mycotoxins.

Area of Science:

  • Immunotoxicology
  • Developmental toxicology
  • Mycotoxicology

Background:

  • Chronic T-2 toxin effects on developing immune systems are not fully understood.
  • Previous studies often focused on single organs or acute toxicity in adults.

Purpose of the Study:

  • To investigate the subchronic immunotoxic effects of T-2 toxin during developmental stages in Wistar juvenile rats.
  • To systematically evaluate T-2 toxin's impact on immune organs, intestinal barrier, immune cell subsets, and cytokine profiles.

Main Methods:

  • Established a 28-day subchronic T-2 toxin exposure model (0-0.8 mg/kg).
  • Assessed immune organ structure (thymus, spleen, lymph nodes).
  • Quantified immune cell populations (NK, myeloid, T/B lymphocytes), cytokine levels, and immunoglobulins (IgA, IgG, IgM).

Main Results:

  • T-2 toxin induced thymic atrophy, splenic damage, and lymph node disorganization.
  • Significant inhibition of NK cell activity and dose-dependent reduction in T and B lymphocyte subsets.
  • Decreased CD4+/CD8+ ratio, reduced immunoglobulin levels, disrupted cytokine secretion, and induced apoptosis.

Conclusions:

  • T-2 toxin causes systemic immune deficiency in developing rats by damaging immune organs and suppressing innate and adaptive immunity.
  • The developing immune system is highly sensitive to T-2 toxin, indicating a need for prevention strategies.
  • Provides a foundation for understanding and managing mycotoxin-induced developmental immunodeficiency.